|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation | |||||
| Stock-based compensation | |||||
| Depreciation & amortization | |||||
| Deferred income taxes | |||||
| Accretion of discount on available-for-sale securities | |||||
| Amortization of debt discount | |||||
| Change in fair value of simple agreements for future equity | |||||
| Impairment of long-lived assets | |||||
| Interest on recourse loan | |||||
| Change in fair value of derivative liability | |||||
| Changes in operating assets and liabilities, net of effects of businesses acquired: | |||||
| Accounts receivable, net | |||||
| Inventory | |||||
| Prepaid expenses | |||||
| Other receivables | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Deferred revenue | |||||
| Operating lease liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of marketable securities | |||||
| Proceeds from maturities and sales of marketable securities | |||||
| Purchases of property and equipment | |||||
| Acquisitions, net of cash acquired | |||||
| Security deposits | |||||
| Capitalized implementation costs | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of common, net of offering costs | |||||
| Proceeds from simple agreement for future equity | |||||
| Proceeds from issuance of common stock under the 2025 Equity Distribution Agreement, net of offering costs | |||||
| Proceeds from exercise of warrants | |||||
| Proceeds from exercise of options | |||||
| Proceeds from note payable | |||||
| Repayments of financing lease liability | |||||
| Proceeds from short-swing profit disgorgement | |||||
| Proceeds from issuance of pre-funded warrants to purchase common stock in connection with private placement, net of issuance costs | |||||
| Proceeds from issuance of common stock under the Sales Agreement and Equity Distribution Agreement, net of offering costs | |||||
| Proceeds from convertible notes payable, net of offering costs | |||||
| Repayments of note payable | |||||
| Proceeds from note payable, related party | |||||
| Repayment of note payable, related party | |||||
| Repayment of lease liability financing | |||||
| Issuance of restricted common stock, net of repurchases | |||||
| Issuance of common stock pursuant to Merger and private placement, net of offering costs | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Operating lease right-of-use assets obtained for lease obligations | |||||
| Derivative liability in connection with convertible note | |||||
| Debt discount issued as accrued liability | |||||
| Conversion of simple agreement for future equity into common stock | |||||
| Conversion of convertible note and derivative into common stock in connection with Merger | |||||
| Warrants issued in connection with note payable | |||||
| Purchases of property and equipment, accrued but not paid | |||||
| Conversion of convertible notes and derivative into common stock | |||||
Loading...